Abstract
Glioblastoma multiforme (GBM) is the most prevalent primary malignant brain tumor, characterized by poor prognosis and low long-term survival rates. Despite advancements in multimodal therapies and a deeper understanding of its biology, treatment remains challenging due to the presence of glioma stem cells, which confer resistance to chemotherapy and radiotherapy, as well as the blood-bra…